Metviron Trio 1 Tablet ER
Marketer
Nvron Life Science Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Metviron Trio 1 Tablet ER
Tri-Diabetic ER, a single-tablet formulation, combats type 2 diabetes in adults. This anti-diabetic medication combines multiple agents to effectively manage blood glucose. For optimal results, consume Tri-Diabetic ER with food at the same time daily. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices are integral to successful diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and always carry a rapid-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. Tri-Diabetic ER is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before starting this medication. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function as directed by your doctor.
Primary Ingredients of Metviron Trio 1 Tablet ER
No information provided. Unable to rewrite.
Uses of Metviron Trio 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Metviron Trio 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Metviron Trio 1 Tablet ER on an empty stomach.
Common Side effects of Metviron Trio 1 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metviron Trio 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Metviron Trio 1 Tablet ER should be taken on an empty stomach.
How Metviron Trio 1 Tablet ER works:
Metviron Trio Extended-Release tablets unite three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metviron Trio 1 Tablet ER and alcohol poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Metviron Trio 1 Tablet ER during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metviron Trio tablets may pose a risk to breastfeeding infants. Available evidence indicates potential transfer to breast milk with possible harm to the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Employing Metviron Trio 1 Tablet ER is likely inadvisable for individuals with impaired renal function and should be avoided. Seek medical counsel. Furthermore, its use is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Metviron Trio 1 Tablet ER cautiously, potentially requiring dosage modification. Those with mild to moderate liver disease should begin with a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction. Physician consultation is advised.
What if you forget to take Metviron Trio 1 Tablet ER :
Should you forget to take a Metviron Trio 1 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metviron Trio 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



